Transcranial and Repetitive Transcranial Magnetic Stimulation Driving a Noninvasive Depression Treatment

These days the most devasting disease that is even worse than the new pandemic COVID19 is commonly spreading and exists is human depression to be more specific. The world-wide episode of depression is something that has no permanent cure either among the youngsters in particular and older people in general. Researchers and scientists in the field of medicine and psychology are looking for some noninvasive approaches to treat this disease. Present chemical medications available in the market that are subscribed to patients are not effective as one set of solution across all the patients and in case of deep depression invasive solution such as clinical Electro-Convulsive Therapy (ECT) in most cases should not be prescribed due to tremendous and devasting side effects of it on patients that are going through such treatment for long term as a means of solution to their depression problem. New studies and clinical results are supporting a new generation of magnetic treatment approach that is known as Transcranial Magnetic Stimulation (TMS) or in case of a longer term suggests repetitive Transcranial Magnetic Stimulation (rTMS), both as very non-invasive approaches with almost no adverse side effects on patients that are receiving such clinical treatments. In this paper we study these two recently approved approaches by Food and Drug Administration (FDA) as well as a newly suggested electric energy medicine by utilizing a new form of wave that is known as a Scalar Wave, which is a non-linear, non-Hertzian, standing wave capable of supporting significant effects including carrying information and inducing higher levels of cellular energy, which greatly enhances the performance and effectiveness of the body and immune system.